Document Detail

Genetics of arterial hypertension and hypotension.
MedLine Citation:
PMID:  17262198     Owner:  NLM     Status:  MEDLINE    
Human hypertension affects affects more than 20% of the adult population in industrialized countries, and it is implicated in millions of deaths worldwide each year from stroke, heart failure and ischemic heart disease. Available evidence suggests a major genetic impact on blood pressure regulation. Studies in monogenic hypertension revealed that renal salt and volume regulation systems are predominantly involved in the genesis of these disorders. Mutations here affect the synthesis of mineralocorticoids, the function of the mineralocorticoid receptor, epithelial sodium channels and their regulation by a new class of kinases, termed WNK kinases. It has been learned from monogenic hypotension that almost all ion transporters involved in the renal uptake of Na(+) have a major impact on blood pressure regulation. For essential hypertension as a complex disease, many candidate genes have been analysed. These include components of the renin-angiotensin-aldosterone system, adducin, beta-adrenoceptors, G protein subunits, regulators of G protein signalling (RGS) proteins, Rho kinases and G protein receptor kinases. At present, the individual impact of common polymorphisms in these genes on the observed blood pressure variation, on risk for stroke and as predictors of antihypertensive responses remains small and clinically irrelevant. Nevertheless, these studies have greatly augmented our knowledge on the regulation of renal functions, cellular signal transduction and the integration of both. Together, this provides the basis for the identification of novel drug targets and, hopefully, innovative antihypertensive drugs.
Dieter Rosskopf; Markus Schürks; Christian Rimmbach; Rafael Schäfers
Related Documents :
1317758 - Platelet cytosolic free calcium concentration, total plasma calcium concentration and b...
17148238 - Propagule pressure and persistence in experimental populations.
12818568 - Transcription factor sp1 regulates serca2 gene expression in pressure-overloaded hearts...
20413898 - Joint effect of hypertension and apoe genotype on csf biomarkers for alzheimer's disease.
19039308 - Association of chronic periodontitis with left ventricular mass and central blood press...
3920388 - Abdominal vascular responses to changes in carbon dioxide tension in the cephalic circu...
Publication Detail:
Type:  Journal Article; Review     Date:  2007-01-30
Journal Detail:
Title:  Naunyn-Schmiedeberg's archives of pharmacology     Volume:  374     ISSN:  0028-1298     ISO Abbreviation:  Naunyn Schmiedebergs Arch. Pharmacol.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-02-07     Completed Date:  2007-06-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0326264     Medline TA:  Naunyn Schmiedebergs Arch Pharmacol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  429-69     Citation Subset:  IM    
Department Pharmacology, Research Center for Pharmacology and Experimental Therapeutics, Ernst-Moritz-Arndt-University Greifswald, Friedrich Loeffler Str. 23d, 17487 Greifswald, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aldosterone / metabolism
Blood Pressure / genetics,  physiology*
Genetic Predisposition to Disease
Hydrocortisone / metabolism
Hypertension / genetics,  metabolism,  physiopathology*
Hypotension / genetics,  metabolism,  physiopathology*
Models, Biological
Receptors, Mineralocorticoid / metabolism
Reg. No./Substance:
0/Receptors, Mineralocorticoid; 50-23-7/Hydrocortisone; 52-39-1/Aldosterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Characterization of the gene Mre11 and evidence of silencing after polyploidization in Triticum.
Next Document:  Factors affecting continence after fistulotomy for intersphincteric fistula-in-ano.